Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Hair Follicle Organoids Using Human iPSC-Derived Ectodermal Precursor Cells for Hair Regenerative Medicine

Kageyama T., Anakama R., Hamano S., Tu S., Migita Y., Asaba T.

Animal Study on Hair Regeneration, published in ACS Biomater Sci Eng (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
ACS Biomater Sci Eng (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41664452
PMCID
PMC12976999
DOI
10.1021/acsbiomaterials.5c01780
Citations
2

Abstract (original English)

Organoids containing hair follicles can be regenerated in vitro using human induced pluripotent stem cells (hiPSCs) and potentially used as a tissue graft for hair regeneration. There are two main approaches to organoid formation: one is to form embryoid bodies from hiPSCs and induce differentiation into several organs and tissues, and the other is to induce tissue precursor epithelial and mesenchymal cells from hiPSCs and coculture them to generate organs and tissues via epithelial-mesenchymal interaction. Our ultimate aim is to differentiate hiPSCs into hair follicle epithelial and mesenchymal stem cells, and to subsequently purify and use them to generate hair follicle organoids (HFOs). We previously showed that murine embryonic skin-derived stem cells could be used to generate mouse HFOs with ∼100% efficiency. However, the key to inducing mouse HFOs is the supplementation of Matrigel at very low concentrations, and this mouse tumor-derived matrix cannot be applied in human treatment. In the current study, we found that collagen I provided a microenvironment for inducing HFOs that was equivalent to that induced by Matrigel. Furthermore, hiPSCs were differentiated into human ectodermal precursor cells and subsequently used to generate human/mouse chimeric HFOs with mouse embryonic mesenchymal cells. The human/mouse chimeric HFOs showed hair follicle sprouting both in vitro an

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Hair FollicleOrganoidsEctodermAnimalsHumansMiceProteoglycansRegenerative MedicineRegenerationCell Differentiation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research